Humeral immune system state in ß thalassemia major

Aim To investigate the humeral immune markers in patients with ß-thalassemia major (TM). Methods In this historical – cohort study (August to December 2007), the case group consisted of 34 TM patients and the control group included the same number of their gender and age matched healthy siblings. Se...

Full description

Bibliographic Details
Main Authors: Javad Ghaffari, Koorosh Vahidshahi, Mehrnoosh Kosaryan, Zahra Soltantooyeh, Mohadese Mohamadi
Format: Article
Language:English
Published: Medical Association of Zenica-Doboj Canton 2011-08-01
Series:Medicinski Glasnik
Subjects:
Online Access:http://www.ljkzedo.com.ba/medglasnik/vol82/MGvol82.2011_4.pdf
Description
Summary:Aim To investigate the humeral immune markers in patients with ß-thalassemia major (TM). Methods In this historical – cohort study (August to December 2007), the case group consisted of 34 TM patients and the control group included the same number of their gender and age matched healthy siblings. Serum levels of CH50, C3, C4, IgE, IgG,IgA,IgM and also ASO & Isohemaglutinin titers were determined and compared between the case and control groups (P<0.05).Results Serum level of IgA in TM patients was more frequently higher than normal level compared to the controls, but there were no significant differences on the level of C3, C4, CH50, IgG, IgE, IgM, ASO and Isohemaglutinin between two groups. Splenectomized patients had lower IgM and higher IgA and IgG levels and also diabetic patients had significantly lower C3, ASO, IgM and higher IgA and IgG levels than other patients. Levels of IgA, IgE, IgG, and ASO increased in elder patients. Patients with serum ferritin level >3000ng/ml had lower C4 and CH50 levels. C4-level in male patients was significantly lower. Conclusion This study indicated that there were no significant changes in humeral immune markers in the patients with ß-thalassemia major compared to the controls, except in the case of IgA which was higher in the TM patients. It seems that there is no need for routine survey of immunoglobulins and complement levels in thalassemic patients in order to detect immunodeficiency.
ISSN:1840-0132
1840-2445